CEO Summary: Mass spectrometry may be ready for a wider audience within clinical laboratories, as the technology’s sensitivity and ease of use provide prime selling points for adoption. However, the expense of the systems, and flat reimbursement rates, may concern cost-sensitive organizations. Clinical lab decision-makers will need to weigh the pros and cons as they […]
To access this post, you must purchase The Dark Report.